Benjamin Maughan, M.D., PharmD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Abbvie
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    AVEO Oncology
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Janssen
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astellas
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bristol-Myers Squibb
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Clovis
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Tempus
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Merck
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exelixis
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2022

Pages

Return to 2022 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes